Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Savara Inc (SVRA)  
$4.41 0.04 (0.9%) as of 4:30 Fri 4/26


Download
   
Exchange: American Stock Exchange
Security Type: Common
Shares Out: 135,340,000
Market Cap: 596.85(M)
Last Volume: 11,363,101 Avg Vol: 11,331,390
52 Week Range: $1.84 - $5.59
Level I Sector: Health Care
Level II Sector: Drugs
Level III Sector: Biotechnology

Member Indexes:
    AMEX COMPOSITE

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Co.'s primary program, molgramostim nebulizer solution is an inhaled biologic, specifically an inhaled granulocyte-macrophage colony-stimulating factor and is being developed for the treatment of autoimmune pulmonary alveolar proteinosis. Molgramostim nebulizer solution is administered once daily by inhalation via a nebulizer, the eFlow® Nebulizer System. The eFlow® Nebulizer System is a reusable electronic inhalation system. Molgramostim was also being investigated in cystic fibrosis (CF) and non-CF patients for the treatment of nontuberculous mycobacterial lung infection, a lung disorder.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 3,439,830 4,023,225
Total Buy Value $0 $0 $10,277,564 $11,106,809
Total People Bought 0 0 12 12
Total Buy Transactions 0 0 14 42
Total Shares Sold 0 187,843 187,843 187,843
Total Sell Value $0 $885,322 $885,322 $885,322
Total People Sold 0 3 3 3
Total Sell Transactions 0 3 3 3
End Date 2024-01-28 2023-10-27 2023-04-28 2022-04-28

   
Records found: 179
  Page 1 of 8  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Erickson Anne Chief Business Officer   •       –      –    2024-04-21 4 D $4.81 $1,833 D/D (381) 353,697     -
   Erickson Anne Chief Business Officer   •       –      –    2024-03-21 3 IO $0.00 $0 D/D 0 354,078 -9%     
   Elam Nevan C Director   –       •      –    2023-12-28 4 S $4.71 $442,291 D/D (93,843) 22,500 8%     
   Elam Nevan C Director   –       •      –    2023-12-28 4 OE $0.82 $69,722 D/D 53,758 116,343     -
   Lowrance David L CHIEF FINANCIAL OFFICER   •       –      –    2023-12-28 4 S $4.71 $47,131 D/D (10,000) 342,355 8%     
   Pauls Matthew CHIEF EXECUTIVE OFFICER   •       •      –    2023-12-28 4 GD $0.00 $0 D/D 19,000 1,283,674     -
   Pauls Matthew CHIEF EXECUTIVE OFFICER   •       •      –    2023-12-28 4 S $4.71 $395,900 D/D (84,000) 1,302,674 8%     
   Lowrance David L CHIEF FINANCIAL OFFICER   •       –      –    2023-12-15 4 GD $0.00 $0 D/D 20,000 352,355     -
   Pratt Raymond Dennis Chief Medical Officer   •       –      –    2023-12-14 4 A $0.00 $0 D/D 150,000 310,000     -
   Sun Ricky   –       •      –    2023-12-14 4 A $0.00 $0 D/D 22,500 22,500     -
   Pauls Matthew CHIEF EXECUTIVE OFFICER   •       •      –    2023-12-14 4 A $0.00 $0 D/D 450,000 1,386,674     -
   Pauls Matthew CHIEF EXECUTIVE OFFICER   •       •      –    2023-12-14 4 D $4.45 $488,076 D/D (109,680) 936,674     -
   Van Es-Johansson An Director   –       •      –    2023-12-14 4 A $0.00 $0 D/D 22,500 22,500     -
   Mccracken Joseph S Director   –       •      –    2023-12-14 4 A $0.00 $0 D/D 22,500 190,837     -
   Elam Nevan C Director   –       •      –    2023-12-14 4 A $0.00 $0 D/D 22,500 62,585     -
   Hawkins Richard J Director   –       •      –    2023-12-14 4 A $0.00 $0 D/D 22,500 35,241     -
   Lutz Robert Matthew Chief Operating Officer   •       –      –    2023-12-14 4 A $0.00 $0 D/D 160,000 300,000     -
   Ramsay David A Director   –       •      –    2023-12-14 4 A $0.00 $0 D/D 22,500 2,223,642     -
   Lowrance David L CHIEF FINANCIAL OFFICER   •       –      –    2023-12-14 4 A $0.00 $0 D/D 160,000 372,355     -
   Lowrance David L CHIEF FINANCIAL OFFICER   •       –      –    2023-12-14 4 D $4.45 $135,449 D/D (30,438) 212,355     -
   Hawkins Richard J Director   –       •      –    2023-12-11 4 OE $0.82 $8,890 D/D 10,841 12,741     -
   Elam Nevan C Director   –       •      –    2023-12-11 4 OE $0.82 $8,890 D/D 10,841 40,085     -
   Florence Anthony A. Jr. 10% Owner   –       –       •   2023-07-17 4 B $3.00 $999,999 I/I 333,333 24,471,264 1.5 19%     
   Makhzoumi Mohamad 10% Owner   –       –       •   2023-07-17 4 B $3.00 $999,999 I/I 333,333 24,471,264 1.5 19%     
   Behbahani Ali 10% Owner   –       –       •   2023-07-17 4 B $3.00 $999,999 I/I 333,333 24,471,264 1.5 19%     
  179 Records found
  1  2  3  4  5  6  7  8   
  Page 1 of 8
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us